4
Changes in Ownership
Corvus Pharmaceuticals, Inc. Filed Acc 0000899243-18-031810
Chief Financial Officer bought 24,700 shares at $4.15 ($102,409)
From the SEC's structured data for this filing
Trades in this filing
LEA LEIV · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-12-21 | Purchase : show line 1 in the form | +24,700 | $4.15 | $102,409 | 24,700 | I |
| Open-market purchases · 24,700 sh · avg $4.15 · $102,409 | ||||||
Loading xslF345X03/doc4.xml…